Physician profile
Robbie L Stringer
NPI 1992194989
$841.67
in general payments reported to CMS, 2019-2025
7 companies · $49.76 in 2025
The $49.76 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $12.50 · 2023: $327 · 2024: $263 · 2025: $49.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $293.36 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Axsome Therapeutics, INC. | $158.27 | 2024 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $156.25 | 2023-2024 | Farxiga |
| Dexcom, INC. | $105.02 | 2021-2023 | Dexcom G7 Gss (161) |
| Bayer Healthcare Pharmaceuticals INC. | $64.23 | 2023-2024 | |
| Stryker Corporation | $49.76 | 2025 | |
| Lilly USA, LLC | $14.78 | 2024 | Zepbound, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robbie Stringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.